CDKN2A and leukemia: Two Early-Pro cases, Ph28-D and Ph50-D, harbored concurrent deletions of EBF1, PAX5, RUNX1 and CDKN2A/B and clustered between Early-Pro and Late-Pro leukemias in PCA (Supplementary Fig. 12).